Page 1 of 79

Mergers & Acquisitions in Pharma Industry

Continues for 78 more pages »
Read full document

Mergers & Acquisitions in Pharma Industry

  • By
  • April 2012
  • 21441 Words
  • 4 Views
Page 1 of 79
PROJECT REPORT
ON
A Successful International Merger in India:
GlaxoSmithKline pharmaceutical industry

Table of Contents:

Declaration
Abstract
Part I –Introduction
Research Objective and justifications
Report Outline
Part-II Industry Description
GSK-The Big Picture
Factors for success in India
References
Part-III Literature review
Chapter One –Merger: An Introduction
1.1 Introduction
1.2 The Main Idea
1.3 Types of Merger
1.4 Reasons for International M&A
Chapter Summary
References
Chapter Two-Nature of Indian pharmaceutical
Industry 2.1 Introduction
2.2 Nature of Indian Pharmaceutical Industry
2.2.1 Industry Scenario
2.2.2 Market Scenario ((Projected Pharmaceutical Market, 2004-2009))
2.2.3 New Product Launches underlie market growth
2.2.5 Key Opportunities
2.2.6 FDI in Indian pharma
2.2.7 Strategy and Trends
2.2.8 Research and Development
2.2.9 SWOT Analysis
2.2.10 Mergers and Acquisitions in Pharma
2.2.11 Good Opportunities for ‘big pharma’
References
Chapter Three-Merger between Glaxo Wellcome
Smithkline Beecham
3.1 Introduction
3.2 Merger rationale
3.2.1 Rapid advances in Science and Technology
3.2.2 The growing importance of marketing power
3.2.3 The emergence of patients as consumers
3.3 Merger Benefits
3.3.1 Short term growth
3.3.2 Medium term growth
3.3.3 Long term growth...

Rate this document

What do you think about the quality of this document?

Share this document

Let your classmates know about this document and more at Studymode.com